Organization · Venture Capital
Omega Funds
Omega Funds is a healthcare-focused venture capital firm based in the U.S. and Switzerland, specializing in innovative therapies for unmet medical needs in the biotech and life sciences sectors.
Overview
What Omega Funds does
What Omega Funds is
Omega Funds is a healthcare-focused venture capital firm based in the U.S. and Switzerland, specializing in innovative therapies for unmet medical needs in the biotech and life sciences sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2004
- Approximate age
- About 22 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Omega Funds elsewhere
Open the official website or a supported primary organization account.
Capability profile
Omega Funds as a funder
Investment thesis
Life sciences VC focused on transformative (not incremental) innovation targeting urgent medical needs. Invests across oncology, immunology, rare diseases, precision medicine, and medical devices.
Focus narrative
Omega Funds invests in various stages of development, from early venture to late-stage, including direct secondaries and company creation. Their focus spans oncology, immunology, rare diseases, precision medicine, and medical devices, aiming to enhance the success of entrepreneurs and their ventures.
Value beyond capital
Omega Funds provides strategic support to portfolio companies by leveraging their extensive network and expertise in the life sciences sector, helping entrepreneurs navigate challenges and accelerate growth.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo · Secondary · Bridge · Recap
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 150
- Recorded notable exits
- Aviceda Therapeutics
Portfolio context
Omega Funds has contributed to the development of 52 products that have reached patients, with a portfolio that includes over 150 companies. Notable achievements include 50 exits via M&A and 47 IPOs/public listings.
Common questions
What to know about Omega Funds
Upseed classifies Omega Funds under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.